Segments - Transcutaneous Electrical Nerve Stimulation Market by Type (Desktop and Portable), Application (Acute Pain and Chronic Pain), End-user (Clinics, Hospitals, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The global transcutaneous electrical nerve stimulation market size was USD 310.29 Million in 2022 and is likely to reach USD 429.46 Million by 2031, expanding at a CAGR of 3.87% during 2023–2031. High demand for pain management therapies and devices is anticipated to propel the market.
Growing prevalence of chronic pain conditions is projected to propel the market during the forecast period. In recent years, there has been an increasing requirement for transcutaneous electrical nerve stimulation among athletes and sports enthusiasts. Furthermore, the high demand for non-invasive pain management in the geriatric demographic, due to the surge in the geriatric population is likely to fuel the market in the coming years.
According to the data published by the World Health Organization (WHO) in 2022, the global population of individuals aged 60 years or older exceeded the number of children aged below five years in 2020. It is projected that nearly 80% of the elderly population is expected to reside in underdeveloped and developing countries by 2050.
The technological advancements have led to significant improvements in transcutaneous electrical nerve stimulation devices in terms of features and connectivity. The awareness of alternative pain management treatments and therapies is rising among the population. Thus, people are increasingly opting for non-pharmacological treatments for drug-free pain relief. These factors are anticipated to boost the market in the coming years.
The COVID-19 pandemic hindered the market. Most of the healthcare resources shifted their focus to treating the infected patients during the pandemic, which decreased the demand for pain management and related therapies. This, in turn, affected the market, as the demand for transcutaneous electrical nerve stimulation devices significantly declined.
The adoption of artificial intelligence is expected to provide substantial propulsion to the transcutaneous electrical nerve stimulation market. The convergence of artificial intelligence (AI), the Internet of Things (IoT), and health monitoring sensors have made it possible to establish a closed-loop system that offers real-time monitoring, data collection, and treatment recommendations. The use of transcutaneous electrical nerve stimulation sensors enhanced by intelligent technologies is vital in terms of providing effective treatment to patients.
Increasing advancements in the technology of electrotherapy devices are expected to drive the market during the projection period. Advanced transcutaneous electrical nerve stimulation (TENS) devices offer features, such as customizable settings for treatment, wireless connectivity, and smartphone applications for remote monitoring and control. These technological innovations enhance the user experience and treatment. The use of such technology makes TENS devices appealing to a wide range of patients, thereby boosting the market.
Problems associated with the use of TENS devices, such as skin irritation, are likely to hamper the market during the forecast period. TENS devices require the placement of adhesive electrodes on the skin, which causes discomfort or irritation. This discourages people from using these devices as a treatment option, which impedes the market during the forecast period.
Surge in product innovation is anticipated to provide substantial growth opportunities for the market. Innovative TENS devices are leading to advanced features and enhanced user experience. The development of portable, compact, and wearable TENS devices is appealing to a large consumer base. In addition, these devices are efficient and user-friendly.
In March 2022, a study by the European Pain Federation supported by several US universities found that the OMRON FocusTM TENS Therapy for the knee (PM-710) device is effective in diminishing pain for people with mild to moderate knee problems, such as wear and tear. It proved to be highly useful, especially during functional tests, such as walking and stair climbing.
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Transcutaneous Electrical Nerve Stimulation Market – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Type (Desktop and Portable), Application (Acute Pain and Chronic Pain), and End-user (Clinics, Hospitals, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
Key Players Covered in the Report |
Zynex Medical; Uroplasty, Inc.; NEVRO CORP.; NeuroMetrix, Inc.; Medtronic; DJO, LLC; Cyberonic Internet Communications, Inc.; BTL Group of Companies; Boston Scientific Corporation; and Abbott |
Based on type, the transcutaneous electrical nerve stimulation market is bifurcated into desktop and portable. The portable segment is projected to hold the major share of the market during the projection period, owing to its ease of use and convenient functionality. Portable transcutaneous electrical nerve stimulation (TENS) devices are often designed with user-friendly interfaces.
This makes them easy to operate without any professional assistance. Furthermore, portable TENS devices allow therapy on the go, providing relief from pain at home, work, or any other location. This makes them highly convenient, thereby boosting the segment.
On the basis of application, the global market is segregated into acute pain and chronic pain. The acute pain segment is further segregated into sports injuries, labor pain, postoperative pain, and menstrual pain. Similarly, the chronic pain segment is divided into arthritis, fibromyalgia, back & neck pain, neuropathic pain, and others.
The acute pain segment is projected to register a considerable CAGR during the forecast period, as TENS devices offer a non-invasive method for managing acute pain. This is especially beneficial when immediate relief is needed without resorting to medication or invasive procedures. Moreover, these devices provide quick relief by stimulating the body’s natural pain management system. This makes it a valuable tool for sudden and severe acute pain, such as post-operative pain and acute injuries. This, in turn, propel the segment.
The chronic pain segment is anticipated to grow rapidly during the projection period, as TENS devices are available in compact and portable forms, making them suitable for use at homes and offices for people suffering from chronic pain. These devices provide a drug-free and non-invasive method of chronic pain management while allowing for a wide range of customizations for specific needs, thereby fueling the segment.
According to a report published by the Centers for Disease Control and Prevention in April 2023, approximately 51.6 million adults (20.9%) in the US experienced chronic pain in 2021. Of these, 17.1 million people (6.9%) had high-impact chronic pain, which severely limits their daily activities. Alaska Native adults or non-Hispanic American Indians, adults identifying as bisexual, and people who were separated or divorced were more likely to report high-impact chronic pain.
Based on end-user, the transcutaneous electrical nerve stimulation market is divided into clinics, hospitals, and others. The clinics segment is anticipated to register a robust growth rate during the projection period, owing to the availability of specialized equipment and trained professionals that allows for the customization of TENS therapy devices based on an individual’s needs.
This helps in safe and effective pain management. In addition, the clinics closely monitor the patient’s progress in the therapy, making real-time adjustments and providing valuable feedback, thereby fueling the segment.
In terms of region, the global transcutaneous electrical nerve stimulation market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period, due to its excellent healthcare analytics system, the presence of several key players, and advanced medical infrastructure.
The rising investments by the governments to develop advanced medical devices are creating potential growth opportunities for the market. In addition, the high disposable income of the consumers and the rising adoption of advanced medical devices and innovative technologies are anticipated to propel the market.
The market in Asia Pacific is projected to expand at a considerable CAGR in the coming years, owing to the increasing awareness of general fitness and health. The high adoption of therapies for pain management and the surging use of smart devices in the health and fitness industry are some of the primary factors responsible for the growth of the market in the region.
Furthermore, the surge in the geriatric population in countries, such as China and Japan, is projected to propel the market during the forecast period.
The transcutaneous electrical nerve stimulation market has been segmented on the basis of
Key players competing in the global transcutaneous electrical nerve stimulation market are Zynex Medical; Uroplasty, Inc.; NEVRO CORP.; NeuroMetrix, Inc.; Medtronic; DJO, LLC; Cyberonic Internet Communications, Inc.; BTL Group of Companies; Boston Scientific Corporation; and Abbott.
These companies adopt numerous development strategies, such as acquisitions, mergers, collaboration, partnerships, product launches, and production expansion, to tap into the untapped regions. These key market players heavily invest in the R&D of innovative devices and treatments to maintain market relevance. For instance,
In April 2021, DJO, LLC, one of the prominent market players, acquired MedShape, Inc., a key provider of innovative surgical solutions for ankle and foot surgeons, to help with soft tissue injury repair, fracture fixation, and joint fusion. This acquisition is intended to help DJO, LLC to expand its business in foot and ankle surgeries.